Team

Camilo is a proven strategic and collaborative leader, with a proven track record of driving performance at the intersection of manufacturing and innovation in the cement and concrete industry. Previously he was president for the Cement Business Unit at Argos USA where he had a career of over 19 years. He has a wealth of experience in taking innovation to successful market commercialization in the building materials industry, as well as entry to new markets. He has led large-scale, multi geography businesses in both developed and developing countries, always with client’s insights and understanding in mind. His experience in R&D, innovation and sustainability bring an insightful perspective to business development and go to market. Camilo’s purpose of driving sustainability in the industry aligns perfectly with Biomason leading the global transition to planet friendly construction through revolutionizing the industry with Biocement.

He holds an MBA from Goizueta Business School at Emory University, a MSc Civil and Environmental Engineering from University of Maryland and a BSc Environmental Engineering from the Escuela de Ingenieria de Antioquia. He has served as a board member of several companies ranging all the way from traditional building materials to green building materials and retail. He currently has the honor to serve as one of the members of the Board of Visitors at UMD Department of Civil and Environmental Engineering.

As the VP of R&D, Ben brings nearly fifteen years of senior R&D leadership experience at leading biotechnology companies. His robust academic training has resulted in multiple publications in Science that unveiled novel microbial physiologies. As the Head of Heterotrophic Cell Systems at Synthetic Genomics, Ben led the technological advancement of a diverse portfolio of non-photosynthetic microbial technologies. Subsequently, as the Senior Director of Biocatalyst Engineering at Genomatica, he oversaw teams of enzyme engineers, synthetic biologists, and automation engineers, facilitating the strain development of multiple bio-based chemicals from pre-pilot to commercial scales.

Ben is deeply committed to leveraging innovative microbial and enzyme biocatalysts to tackle global sustainability challenges. He is at the forefront of advancing industrial biotechnology, developing efficient and effective strain development platforms that marry cutting-edge technology with a robust scientific and operational foundation.

Ben's academic journey commenced with a Bachelor of Science in Biology from the University of Puget Sound, followed by a PhD. in Microbiology and Environmental Toxicology from Michigan State University. His postdoctoral research at the University of Konstanz in Germany and the Institute for Genomic Biology at the University of Illinois Urbana-Champaign broadened his expertise in microbial physiology and genetics, contributing new insights to the field.

Jan leads Biomason's business development in Europe. He brings over 25 years of international experience in the broader semiconductor and PV industries, with demonstrated excellence in R&D and project management, international business development, management, and marketing and sales. His track record of successful strategic and tactical leadership in positions at global institutions such as Imec, Intel, and Alcatel Microelectronics aided his transition to senior business and technology development roles at Metron Technology, Roth & Rau, and Activ Solar. Prior to joining Biomason, Jan established his own consultancy firm, consulting on projects within the broader technology market, focusing on renewable energy and microelectronics. Previous projects include full business planning for a Brazilian PV module factory, business development for a Swiss R&D PV center, and commercial management of a French solar module fabrication equipment start-up.

As the Director of Program Innovation, Christina is responsible for shaping and driving the successful execution of Biomason's strategic initiatives and R&D programs. At the intersection of business and technology, she aims to align research activities to serve the most valuable and pressing opportunities unique to Biomason's technology. She is passionate about leveraging biotechnology to change our everyday products for a healthier, more sustainable future.

Christina brings 15 years of experience in the biotechnology industry, leading research and commercialization activities across the fuels, specialty chemicals, apparel, beauty & personal care, and food & nutrition markets. Prior to Biomason, she led Strategy and Business Operations at Geltor with a focus on analyzing, developing, and implementing new product and go-to-market strategies for biodesigned proteins. She also led Technical Programs at Bolt Threads, with the aim of developing and scaling biobased materials for sustainable textiles. Christina received her BSE in Chemical and Biomolecular Engineering from the University of Pennsylvania and her MBA from UC Berkeley's Haas School of Business.

Carmen is responsible for directing Biomason’s R&D Services team which focuses on lab and pilot scale operations, analytical chemistry, material testing and characterization, engineering, and data management. After receiving a B.S. in Biology from SUNY Plattsburgh, Carmen completed graduate studies in chemistry at NC State with thesis research in establishing capillary electrophoretic techniques for the identification of enzyme binding domains. His experience spans over 27 years in industrial biotechnology from bench to production scale providing leadership for growth initiatives and new product development. Carmen has also developed and led the strategic direction and alignment of laboratory automation systems, data management systems, and IT infrastructure for multidisciplinary, global R&D teams. He has created value with enzyme applications for customers across multiple industries including biofuels, chemical and biological weapon decontamination, pesticide degradation, grain processing, and personal care.

As a Director of Tech Transfer, Josh supports deployment of Biomason’s processes to clients around the globe. Josh brings 15 years of experience to the role, with a background in technology and process development within a variety of roles in the biopharmaceutical industry. He has supported technology transfer initiatives across a variety of programs, including small molecule drugs, fermentation of industrial enzymes, and cell and gene therapies. Prior to joining Biomason, he held positions at Pfizer, Humacyte, and Novozymes. He received a BS in chemical engineering from NC State University and completed a Ph.D. in chemical engineering at the University of Colorado at Boulder.

Peder’s career spans over 35 years at the largest bioindustrial company, Novozymes. Trained in chemical engineering and business development, he started in innovation and research, but quickly moved onto business management with 25 years on the executive board, of which he was CEO for the last 7 years. He is a strong voice in sustainability and was the only business leader invited to speak at the UN General Assembly when the Sustainable Development Goals were adopted in 2015. Since retiring from Novozymes, Peder invests in sustainability and helps companies bring sustainable technologies to market. Peder has been on the board of LEO Pharma and Hempel, and he has been on the board of trustees of The Eisenhower Foundation, The United States Council for International Business, and the ICC’s B20 group. He and his wife are the primary sponsors of Borneo Child Aid, supporting over 2000 children in Southeast Asia.

Peder holds a Ph.D. and M.S. in Chemical Engineering from the Technical University of Denmark and a degree in international commerce from Copenhagen Business School. Additionally, he has attended management training programs at INSEAD and Stanford.

Camilo is a proven strategic and collaborative leader, with a proven track record of driving performance at the intersection of manufacturing and innovation in the cement and concrete industry. Previously he was president for the Cement Business Unit at Argos USA where he had a career of over 19 years. He has a wealth of experience in taking innovation to successful market commercialization in the building materials industry, as well as entry to new markets. He has led large-scale, multi geography businesses in both developed and developing countries, always with client’s insights and understanding in mind. His experience in R&D, innovation and sustainability bring an insightful perspective to business development and go to market. Camilo’s purpose of driving sustainability in the industry aligns perfectly with Biomason leading the global transition to planet friendly construction through revolutionizing the industry with Biocement.

He holds an MBA from Goizueta Business School at Emory University, a MSc Civil and Environmental Engineering from University of Maryland and a BSc Environmental Engineering from the Escuela de Ingenieria de Antioquia. He has served as a board member of several companies ranging all the way from traditional building materials to green building materials and retail. He currently has the honor to serve as one of the members of the Board of Visitors at UMD Department of Civil and Environmental Engineering.

Prior to co-founding 2150, Christian held leadership roles in global industrial B2B companies such as Coloplast and ROCKWOOL driving changes focused on commercial development, digitalisation and sustainability. He co-founded and chaired SYNERGI, an organization focused on climate and energy efficiency bringing together large industry participants like Danfoss, Grundfos, Velux and others to lobby for Danish and European policy changes to reach the Paris Climate Agreement. Today, he is advisor to the Foundation for Climate Restoration in California.

Christian holds a Masters in Finance and International Business from Aarhus University and an executive degree from INSEAD. When not with his wife and three kids, Christian enjoys spending time off-trail running or exploring nature. His personal commitment to sustainability in 2022 to bring his kids to kindergarten on the Christiania bike to further reduce his CO2 footprint.

Cynthia Kueppers is an experienced private equity investor. She is a Partner on the Planetary Health Investment team at Novo Holdings, the investment company managing the assets for the Novo Nordisk Foundation, one of the world’s largest private foundations. She is investing in high growth companies that support a sustainable planet in areas of energy, agriculture, cities and materials. Previously, she was a Managing Director at Riverstone Holdings, investing in industrial decarbonization, and prior to that she was an investment banker on Wall Street covering transportation and infrastructure. She serves as a board member for various portfolio companies and not-for-profits. She has an MBA from Yale, a BA from the University of Pennsylvania and is a Chartered Financial Analyst (CFA).